@markhorn91
Active 2 years, 11 months ago
62%, s = .Goal). These kind of results stay after multivariate adjusting, demonstrating once a week management had been more efficient in the luminal-B (HER2-positive) subgroup (g = .10) and not in the ERBB2+ subgroup (s Equals .55).
Conclusion. A more regular administration may increase the chance of eliminating invasive most cancers […] View